TNFRSF14 was associated with a better prognosis through promotion of apoptosis in BLCA [82], whereas TNFRSF25 mediated toxic killing of CD8 T cells to exert antitumor immunity [83]. This evidence concerns the gene TNFRSF14 and bladder transitional cell carcinoma.